Brian Richard MacDonald - 28 Jun 2023 Form 4 Insider Report for Disc Medicine, Inc. (IRON)

Signature
By: /s/ Rahul Khara, as Attorney-in-Fact
Issuer symbol
IRON
Transactions as of
28 Jun 2023
Net transactions value
-$655,024
Form type
4
Filing time
30 Jun 2023, 18:29:14 UTC
Previous filing
03 Jan 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRON Common Stock Sale $110,649 -2,247 -8.2% $49.24 25,153 28 Jun 2023 Direct F1, F2
transaction IRON Common Stock Sale $95,730 -1,900 -7.6% $50.38 23,253 28 Jun 2023 Direct F1, F3
transaction IRON Common Stock Sale $48,415 -953 -4.1% $50.80 22,300 28 Jun 2023 Direct F1, F4
transaction IRON Common Stock Sale $32,656 -736 -3.3% $44.37 21,564 29 Jun 2023 Direct F1, F5
transaction IRON Common Stock Sale $101,453 -2,230 -10% $45.49 19,334 29 Jun 2023 Direct F1, F6
transaction IRON Common Stock Sale $89,952 -1,934 -10% $46.51 17,400 29 Jun 2023 Direct F1, F7
transaction IRON Common Stock Sale $9,448 -200 -1.1% $47.24 17,200 29 Jun 2023 Direct F1, F8
transaction IRON Common Stock Sale $131,102 -2,923 -17% $44.85 14,277 30 Jun 2023 Direct F1, F9
transaction IRON Common Stock Sale $63,676 -1,401 -9.8% $45.45 12,876 30 Jun 2023 Direct F1, F10
transaction IRON Common Stock Sale $28,058 +600 +5.1% $46.76 12,276 30 Jun 2023 Direct F1, F11
holding IRON Common Stock 1,096 28 Jun 2023 Held by Son F12
holding IRON Common Stock 1,096 28 Jun 2023 Held by Son F12
holding IRON Common Stock 1,096 28 Jun 2023 Held by Son F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on February 17, 2023.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.61 to $49.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (11) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.61 to $50.59, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.62 to $51.235, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.03 to $44.87, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.03 to $45.94, inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.04 to $46.96, inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.23 to $47.25, inclusive.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.31 to $45.29, inclusive.
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.31 to $45.58, inclusiv
F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.56 to $47.00, inclusive.
F12 The Reporting Person disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly.